Search
Now showing items 1-10 of 14
The consumer welfare implications of governmental policies and firm strategy in markets for medicines
(Elsevier, 2015)
This paper empirically examines the consumer welfare implications of changes in government policies related to patent protection and compulsory licensing in the Indian market for oral anti-diabetic (OAD) medicines. In ...
When the big one came: a natural experiment on demand shock and market structure in India’s influenza vaccine markets
(John Wiley, 2018-08)
This paper examines the relationship between exogenous demand shock and market structure in India’s influenza vaccine markets. Using a novel dataset of detailed purchasing information for vaccines ...
Competition law in india: perspectives
(Sage, 2016)
In 2002, the Parliament of India enacted the Competition Act, replacing the
archaic Monopoly and Restrictive Trade Practices Act (popularly referred to as
the MRTP Act) of 1969. The primary goal of the Act, as stated in ...
Crocin or paracetamol: what should the doctor prescribe?
(Economic & Political Weekly, 2013)
As the Indian government contemplates enacting generic name-based prescriptions, it is important to understand the pros and cons of such regulation. This article points out various advantages associated with such changes ...
Balancing affordability and availability in a drug patent regime
(Economic and Political Weekly, 2015)
India needs to fi
nd an optimal
patenting regime that will
safeguard incentives for
innovation while simultaneously
ensuring that medicines are
available at reasonable prices.
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling
(Research Policy, 2020-09-12)
We provide causal evidence that regulation induced product shocks significantly impact aggregate demand and firm performance in pharmaceutical markets. Event study results suggest an average loss between $569 million and ...
Intellectual property regimes and wage inequality
(Elsevier, 2021-07-19)
We use The Patents (Amendment) Act, 2002 in India as a quasi-natural experiment to identify the causal effect of higher incentives for innovation on a firm’s compensation structure. We find that stronger intellectual ...
How does regulation impact strategic repositioning by firms across submarkets? evidence from the Indian pharmaceutical industry
(INFORMS: Institute for Operations Research and the Management Sciences, 2021-02-09)
We study coercive institutional pressures as an impetus for firms to reposition across intraindustry boundaries. Integrating the literatures on strategic repositioning and submarkets, we predict that firms respond to ...
Women’s disempowerment and preferences for skin lightening products that reinforce Colorism: experimental evidence from India
(SAGE Publications, 2021-02-25)
Global racism and colorism, the preference for fairer skin even within ethnic and racial groups, leads millions of women of African, Asian, and Latin descent to use products with chemical ingredients intended to lighten ...
Generic competition and the incentives for early-stage pharmaceutical innovation
(Elsevier, 2022-12-01)
What impact has rising generic competition had on the nature and direction of pharmaceutical innovation? We find broad-based, strong evidence that pharmaceutical companies have diverted their new drug development efforts ...